Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors
Although the neutrophil-lymphocyte ratio (NLR) is prognostic in many oncological settings, its significance in the immunotherapy era is unknown. Mechanistically, PD-1/PD-L1 inhibitors may alter NLR. We sought to characterise NLR kinetics in patients with advanced solid tumours treated with PD-1/PD-L...
Ausführliche Beschreibung
Gespeichert in:
| Autor*in: |
Ameratunga, Malaka [verfasserIn] |
|---|
| Format: |
E-Artikel |
|---|---|
| Sprache: |
Englisch |
| Erschienen: |
2018 |
|---|
| Schlagwörter: |
|---|
| Umfang: |
8 |
|---|
| Übergeordnetes Werk: |
Enthalten in: The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study - Hamzah, N. ELSEVIER, 2018, Amsterdam [u.a.] |
|---|---|
| Übergeordnetes Werk: |
volume:89 ; year:2018 ; pages:56-63 ; extent:8 |
| Links: |
|---|
| DOI / URN: |
10.1016/j.ejca.2017.11.012 |
|---|
| Katalog-ID: |
ELV041596315 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | ELV041596315 | ||
| 003 | DE-627 | ||
| 005 | 20230624090235.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180726s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ejca.2017.11.012 |2 doi | |
| 028 | 5 | 2 | |a GBV00000000000094A.pica |
| 035 | |a (DE-627)ELV041596315 | ||
| 035 | |a (ELSEVIER)S0959-8049(17)31409-0 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | |a 610 | |
| 082 | 0 | 4 | |a 610 |q DE-600 |
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 44.52 |2 bkl | ||
| 100 | 1 | |a Ameratunga, Malaka |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors |
| 264 | 1 | |c 2018 | |
| 300 | |a 8 | ||
| 336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
| 337 | |a nicht spezifiziert |b z |2 rdamedia | ||
| 338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
| 520 | |a Although the neutrophil-lymphocyte ratio (NLR) is prognostic in many oncological settings, its significance in the immunotherapy era is unknown. Mechanistically, PD-1/PD-L1 inhibitors may alter NLR. We sought to characterise NLR kinetics in patients with advanced solid tumours treated with PD-1/PD-L1 inhibitors. | ||
| 650 | 7 | |a PD-1 inhibitors |2 Elsevier | |
| 650 | 7 | |a Neutrophil-lymphocyte ratio |2 Elsevier | |
| 650 | 7 | |a Phase I trials |2 Elsevier | |
| 700 | 1 | |a Chénard-Poirier, Maxime |4 oth | |
| 700 | 1 | |a Moreno Candilejo, Irene |4 oth | |
| 700 | 1 | |a Pedregal, Manuel |4 oth | |
| 700 | 1 | |a Lui, Andrew |4 oth | |
| 700 | 1 | |a Dolling, David |4 oth | |
| 700 | 1 | |a Aversa, Caterina |4 oth | |
| 700 | 1 | |a Ingles Garces, Alvaro |4 oth | |
| 700 | 1 | |a Ang, Joo Ern |4 oth | |
| 700 | 1 | |a Banerji, Udai |4 oth | |
| 700 | 1 | |a Kaye, Stan |4 oth | |
| 700 | 1 | |a Gan, Hui |4 oth | |
| 700 | 1 | |a Doger, Bernard |4 oth | |
| 700 | 1 | |a Moreno, Victor |4 oth | |
| 700 | 1 | |a de Bono, Johann |4 oth | |
| 700 | 1 | |a Lopez, Juanita |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |n Elsevier |a Hamzah, N. ELSEVIER |t The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study |d 2018 |g Amsterdam [u.a.] |w (DE-627)ELV000241849 |
| 773 | 1 | 8 | |g volume:89 |g year:2018 |g pages:56-63 |g extent:8 |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.ejca.2017.11.012 |3 Volltext |
| 912 | |a GBV_USEFLAG_U | ||
| 912 | |a GBV_ELV | ||
| 912 | |a SYSFLAG_U | ||
| 936 | b | k | |a 44.52 |j Therapie |x Medizin |q VZ |
| 951 | |a AR | ||
| 952 | |d 89 |j 2018 |h 56-63 |g 8 | ||
| 953 | |2 045F |a 610 | ||
| author_variant |
m a ma |
|---|---|
| matchkey_str |
ameratungamalakachnardpoiriermaximemoren:2018----:etohlypoyeaikntciptetwtavneslduoropae |
| hierarchy_sort_str |
2018 |
| bklnumber |
44.52 |
| publishDate |
2018 |
| allfields |
10.1016/j.ejca.2017.11.012 doi GBV00000000000094A.pica (DE-627)ELV041596315 (ELSEVIER)S0959-8049(17)31409-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.52 bkl Ameratunga, Malaka verfasserin aut Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors 2018 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Although the neutrophil-lymphocyte ratio (NLR) is prognostic in many oncological settings, its significance in the immunotherapy era is unknown. Mechanistically, PD-1/PD-L1 inhibitors may alter NLR. We sought to characterise NLR kinetics in patients with advanced solid tumours treated with PD-1/PD-L1 inhibitors. PD-1 inhibitors Elsevier Neutrophil-lymphocyte ratio Elsevier Phase I trials Elsevier Chénard-Poirier, Maxime oth Moreno Candilejo, Irene oth Pedregal, Manuel oth Lui, Andrew oth Dolling, David oth Aversa, Caterina oth Ingles Garces, Alvaro oth Ang, Joo Ern oth Banerji, Udai oth Kaye, Stan oth Gan, Hui oth Doger, Bernard oth Moreno, Victor oth de Bono, Johann oth Lopez, Juanita oth Enthalten in Elsevier Hamzah, N. ELSEVIER The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study 2018 Amsterdam [u.a.] (DE-627)ELV000241849 volume:89 year:2018 pages:56-63 extent:8 https://doi.org/10.1016/j.ejca.2017.11.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.52 Therapie Medizin VZ AR 89 2018 56-63 8 045F 610 |
| spelling |
10.1016/j.ejca.2017.11.012 doi GBV00000000000094A.pica (DE-627)ELV041596315 (ELSEVIER)S0959-8049(17)31409-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.52 bkl Ameratunga, Malaka verfasserin aut Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors 2018 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Although the neutrophil-lymphocyte ratio (NLR) is prognostic in many oncological settings, its significance in the immunotherapy era is unknown. Mechanistically, PD-1/PD-L1 inhibitors may alter NLR. We sought to characterise NLR kinetics in patients with advanced solid tumours treated with PD-1/PD-L1 inhibitors. PD-1 inhibitors Elsevier Neutrophil-lymphocyte ratio Elsevier Phase I trials Elsevier Chénard-Poirier, Maxime oth Moreno Candilejo, Irene oth Pedregal, Manuel oth Lui, Andrew oth Dolling, David oth Aversa, Caterina oth Ingles Garces, Alvaro oth Ang, Joo Ern oth Banerji, Udai oth Kaye, Stan oth Gan, Hui oth Doger, Bernard oth Moreno, Victor oth de Bono, Johann oth Lopez, Juanita oth Enthalten in Elsevier Hamzah, N. ELSEVIER The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study 2018 Amsterdam [u.a.] (DE-627)ELV000241849 volume:89 year:2018 pages:56-63 extent:8 https://doi.org/10.1016/j.ejca.2017.11.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.52 Therapie Medizin VZ AR 89 2018 56-63 8 045F 610 |
| allfields_unstemmed |
10.1016/j.ejca.2017.11.012 doi GBV00000000000094A.pica (DE-627)ELV041596315 (ELSEVIER)S0959-8049(17)31409-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.52 bkl Ameratunga, Malaka verfasserin aut Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors 2018 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Although the neutrophil-lymphocyte ratio (NLR) is prognostic in many oncological settings, its significance in the immunotherapy era is unknown. Mechanistically, PD-1/PD-L1 inhibitors may alter NLR. We sought to characterise NLR kinetics in patients with advanced solid tumours treated with PD-1/PD-L1 inhibitors. PD-1 inhibitors Elsevier Neutrophil-lymphocyte ratio Elsevier Phase I trials Elsevier Chénard-Poirier, Maxime oth Moreno Candilejo, Irene oth Pedregal, Manuel oth Lui, Andrew oth Dolling, David oth Aversa, Caterina oth Ingles Garces, Alvaro oth Ang, Joo Ern oth Banerji, Udai oth Kaye, Stan oth Gan, Hui oth Doger, Bernard oth Moreno, Victor oth de Bono, Johann oth Lopez, Juanita oth Enthalten in Elsevier Hamzah, N. ELSEVIER The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study 2018 Amsterdam [u.a.] (DE-627)ELV000241849 volume:89 year:2018 pages:56-63 extent:8 https://doi.org/10.1016/j.ejca.2017.11.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.52 Therapie Medizin VZ AR 89 2018 56-63 8 045F 610 |
| allfieldsGer |
10.1016/j.ejca.2017.11.012 doi GBV00000000000094A.pica (DE-627)ELV041596315 (ELSEVIER)S0959-8049(17)31409-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.52 bkl Ameratunga, Malaka verfasserin aut Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors 2018 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Although the neutrophil-lymphocyte ratio (NLR) is prognostic in many oncological settings, its significance in the immunotherapy era is unknown. Mechanistically, PD-1/PD-L1 inhibitors may alter NLR. We sought to characterise NLR kinetics in patients with advanced solid tumours treated with PD-1/PD-L1 inhibitors. PD-1 inhibitors Elsevier Neutrophil-lymphocyte ratio Elsevier Phase I trials Elsevier Chénard-Poirier, Maxime oth Moreno Candilejo, Irene oth Pedregal, Manuel oth Lui, Andrew oth Dolling, David oth Aversa, Caterina oth Ingles Garces, Alvaro oth Ang, Joo Ern oth Banerji, Udai oth Kaye, Stan oth Gan, Hui oth Doger, Bernard oth Moreno, Victor oth de Bono, Johann oth Lopez, Juanita oth Enthalten in Elsevier Hamzah, N. ELSEVIER The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study 2018 Amsterdam [u.a.] (DE-627)ELV000241849 volume:89 year:2018 pages:56-63 extent:8 https://doi.org/10.1016/j.ejca.2017.11.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.52 Therapie Medizin VZ AR 89 2018 56-63 8 045F 610 |
| allfieldsSound |
10.1016/j.ejca.2017.11.012 doi GBV00000000000094A.pica (DE-627)ELV041596315 (ELSEVIER)S0959-8049(17)31409-0 DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.52 bkl Ameratunga, Malaka verfasserin aut Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors 2018 8 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Although the neutrophil-lymphocyte ratio (NLR) is prognostic in many oncological settings, its significance in the immunotherapy era is unknown. Mechanistically, PD-1/PD-L1 inhibitors may alter NLR. We sought to characterise NLR kinetics in patients with advanced solid tumours treated with PD-1/PD-L1 inhibitors. PD-1 inhibitors Elsevier Neutrophil-lymphocyte ratio Elsevier Phase I trials Elsevier Chénard-Poirier, Maxime oth Moreno Candilejo, Irene oth Pedregal, Manuel oth Lui, Andrew oth Dolling, David oth Aversa, Caterina oth Ingles Garces, Alvaro oth Ang, Joo Ern oth Banerji, Udai oth Kaye, Stan oth Gan, Hui oth Doger, Bernard oth Moreno, Victor oth de Bono, Johann oth Lopez, Juanita oth Enthalten in Elsevier Hamzah, N. ELSEVIER The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study 2018 Amsterdam [u.a.] (DE-627)ELV000241849 volume:89 year:2018 pages:56-63 extent:8 https://doi.org/10.1016/j.ejca.2017.11.012 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U 44.52 Therapie Medizin VZ AR 89 2018 56-63 8 045F 610 |
| language |
English |
| source |
Enthalten in The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study Amsterdam [u.a.] volume:89 year:2018 pages:56-63 extent:8 |
| sourceStr |
Enthalten in The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study Amsterdam [u.a.] volume:89 year:2018 pages:56-63 extent:8 |
| format_phy_str_mv |
Article |
| bklname |
Therapie |
| institution |
findex.gbv.de |
| topic_facet |
PD-1 inhibitors Neutrophil-lymphocyte ratio Phase I trials |
| dewey-raw |
610 |
| isfreeaccess_bool |
false |
| container_title |
The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study |
| authorswithroles_txt_mv |
Ameratunga, Malaka @@aut@@ Chénard-Poirier, Maxime @@oth@@ Moreno Candilejo, Irene @@oth@@ Pedregal, Manuel @@oth@@ Lui, Andrew @@oth@@ Dolling, David @@oth@@ Aversa, Caterina @@oth@@ Ingles Garces, Alvaro @@oth@@ Ang, Joo Ern @@oth@@ Banerji, Udai @@oth@@ Kaye, Stan @@oth@@ Gan, Hui @@oth@@ Doger, Bernard @@oth@@ Moreno, Victor @@oth@@ de Bono, Johann @@oth@@ Lopez, Juanita @@oth@@ |
| publishDateDaySort_date |
2018-01-01T00:00:00Z |
| hierarchy_top_id |
ELV000241849 |
| dewey-sort |
3610 |
| id |
ELV041596315 |
| language_de |
englisch |
| fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV041596315</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624090235.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ejca.2017.11.012</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000094A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV041596315</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0959-8049(17)31409-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ameratunga, Malaka</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Although the neutrophil-lymphocyte ratio (NLR) is prognostic in many oncological settings, its significance in the immunotherapy era is unknown. Mechanistically, PD-1/PD-L1 inhibitors may alter NLR. We sought to characterise NLR kinetics in patients with advanced solid tumours treated with PD-1/PD-L1 inhibitors.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PD-1 inhibitors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neutrophil-lymphocyte ratio</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Phase I trials</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chénard-Poirier, Maxime</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moreno Candilejo, Irene</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pedregal, Manuel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lui, Andrew</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dolling, David</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aversa, Caterina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ingles Garces, Alvaro</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ang, Joo Ern</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Banerji, Udai</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kaye, Stan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gan, Hui</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Doger, Bernard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moreno, Victor</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">de Bono, Johann</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lopez, Juanita</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Hamzah, N. ELSEVIER</subfield><subfield code="t">The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study</subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000241849</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:89</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:56-63</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ejca.2017.11.012</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.52</subfield><subfield code="j">Therapie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">89</subfield><subfield code="j">2018</subfield><subfield code="h">56-63</subfield><subfield code="g">8</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| author |
Ameratunga, Malaka |
| spellingShingle |
Ameratunga, Malaka ddc 610 bkl 44.52 Elsevier PD-1 inhibitors Elsevier Neutrophil-lymphocyte ratio Elsevier Phase I trials Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors |
| authorStr |
Ameratunga, Malaka |
| ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV000241849 |
| format |
electronic Article |
| dewey-ones |
610 - Medicine & health |
| delete_txt_mv |
keep |
| author_role |
aut |
| collection |
elsevier |
| remote_str |
true |
| illustrated |
Not Illustrated |
| topic_title |
610 610 DE-600 610 VZ 44.52 bkl Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors PD-1 inhibitors Elsevier Neutrophil-lymphocyte ratio Elsevier Phase I trials Elsevier |
| topic |
ddc 610 bkl 44.52 Elsevier PD-1 inhibitors Elsevier Neutrophil-lymphocyte ratio Elsevier Phase I trials |
| topic_unstemmed |
ddc 610 bkl 44.52 Elsevier PD-1 inhibitors Elsevier Neutrophil-lymphocyte ratio Elsevier Phase I trials |
| topic_browse |
ddc 610 bkl 44.52 Elsevier PD-1 inhibitors Elsevier Neutrophil-lymphocyte ratio Elsevier Phase I trials |
| format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
| format_main_str_mv |
Text Zeitschrift/Artikel |
| carriertype_str_mv |
zu |
| author2_variant |
m c p mcp c i m ci cim m p mp a l al d d dd c a ca g a i ga gai j e a je jea u b ub s k sk h g hg b d bd v m vm b j d bj bjd j l jl |
| hierarchy_parent_title |
The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study |
| hierarchy_parent_id |
ELV000241849 |
| dewey-tens |
610 - Medicine & health |
| hierarchy_top_title |
The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study |
| isfreeaccess_txt |
false |
| familylinks_str_mv |
(DE-627)ELV000241849 |
| title |
Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors |
| ctrlnum |
(DE-627)ELV041596315 (ELSEVIER)S0959-8049(17)31409-0 |
| title_full |
Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors |
| author_sort |
Ameratunga, Malaka |
| journal |
The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study |
| journalStr |
The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study |
| lang_code |
eng |
| isOA_bool |
false |
| dewey-hundreds |
600 - Technology |
| recordtype |
marc |
| publishDateSort |
2018 |
| contenttype_str_mv |
zzz |
| container_start_page |
56 |
| author_browse |
Ameratunga, Malaka |
| container_volume |
89 |
| physical |
8 |
| class |
610 610 DE-600 610 VZ 44.52 bkl |
| format_se |
Elektronische Aufsätze |
| author-letter |
Ameratunga, Malaka |
| doi_str_mv |
10.1016/j.ejca.2017.11.012 |
| dewey-full |
610 |
| title_sort |
neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase i trials of pd-1/pd-l1 inhibitors |
| title_auth |
Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors |
| abstract |
Although the neutrophil-lymphocyte ratio (NLR) is prognostic in many oncological settings, its significance in the immunotherapy era is unknown. Mechanistically, PD-1/PD-L1 inhibitors may alter NLR. We sought to characterise NLR kinetics in patients with advanced solid tumours treated with PD-1/PD-L1 inhibitors. |
| abstractGer |
Although the neutrophil-lymphocyte ratio (NLR) is prognostic in many oncological settings, its significance in the immunotherapy era is unknown. Mechanistically, PD-1/PD-L1 inhibitors may alter NLR. We sought to characterise NLR kinetics in patients with advanced solid tumours treated with PD-1/PD-L1 inhibitors. |
| abstract_unstemmed |
Although the neutrophil-lymphocyte ratio (NLR) is prognostic in many oncological settings, its significance in the immunotherapy era is unknown. Mechanistically, PD-1/PD-L1 inhibitors may alter NLR. We sought to characterise NLR kinetics in patients with advanced solid tumours treated with PD-1/PD-L1 inhibitors. |
| collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U |
| title_short |
Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors |
| url |
https://doi.org/10.1016/j.ejca.2017.11.012 |
| remote_bool |
true |
| author2 |
Chénard-Poirier, Maxime Moreno Candilejo, Irene Pedregal, Manuel Lui, Andrew Dolling, David Aversa, Caterina Ingles Garces, Alvaro Ang, Joo Ern Banerji, Udai Kaye, Stan Gan, Hui Doger, Bernard Moreno, Victor de Bono, Johann Lopez, Juanita |
| author2Str |
Chénard-Poirier, Maxime Moreno Candilejo, Irene Pedregal, Manuel Lui, Andrew Dolling, David Aversa, Caterina Ingles Garces, Alvaro Ang, Joo Ern Banerji, Udai Kaye, Stan Gan, Hui Doger, Bernard Moreno, Victor de Bono, Johann Lopez, Juanita |
| ppnlink |
ELV000241849 |
| mediatype_str_mv |
z |
| isOA_txt |
false |
| hochschulschrift_bool |
false |
| author2_role |
oth oth oth oth oth oth oth oth oth oth oth oth oth oth oth |
| doi_str |
10.1016/j.ejca.2017.11.012 |
| up_date |
2024-07-06T20:33:30.882Z |
| _version_ |
1803863207060701184 |
| fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV041596315</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624090235.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ejca.2017.11.012</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000094A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV041596315</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0959-8049(17)31409-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ameratunga, Malaka</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Neutrophil-lymphocyte ratio kinetics in patients with advanced solid tumours on phase I trials of PD-1/PD-L1 inhibitors</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">8</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Although the neutrophil-lymphocyte ratio (NLR) is prognostic in many oncological settings, its significance in the immunotherapy era is unknown. Mechanistically, PD-1/PD-L1 inhibitors may alter NLR. We sought to characterise NLR kinetics in patients with advanced solid tumours treated with PD-1/PD-L1 inhibitors.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PD-1 inhibitors</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Neutrophil-lymphocyte ratio</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Phase I trials</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Chénard-Poirier, Maxime</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moreno Candilejo, Irene</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pedregal, Manuel</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lui, Andrew</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Dolling, David</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Aversa, Caterina</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ingles Garces, Alvaro</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ang, Joo Ern</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Banerji, Udai</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kaye, Stan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Gan, Hui</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Doger, Bernard</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Moreno, Victor</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">de Bono, Johann</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Lopez, Juanita</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">Hamzah, N. ELSEVIER</subfield><subfield code="t">The effect of early cognitive therapy in improving cognitive functions using neuropsychology and diffusion tensor imaging measurements following mild traumatic brain injury: A pilot study</subfield><subfield code="d">2018</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV000241849</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:89</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:56-63</subfield><subfield code="g">extent:8</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ejca.2017.11.012</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.52</subfield><subfield code="j">Therapie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">89</subfield><subfield code="j">2018</subfield><subfield code="h">56-63</subfield><subfield code="g">8</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
| score |
7.400281 |